Neogenomics (NEO) Receivables - Net (2010 - 2026)

Neogenomics (NEO) has reported Receivables - Net for 17 consecutive years, with $167.4 million the latest figure, recorded in Q1 2026.

• Receivables - Net for Q1 2026 came in at $167.4 million, up 10.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $167.4 million (up 10.72% YoY), and the FY2025 annual result was $159.2 million, up 5.78% from the prior year.
• Receivables - Net was $167.4 million for Q1 2026 at Neogenomics, up from $159.2 million in the prior quarter.
• Over five years, Receivables - Net peaked at $167.4 million in Q1 2026 and troughed at $110.8 million in Q1 2022.
• Average Receivables - Net over 5 years is $137.5 million, with a median of $140.3 million recorded in 2024.
• Year-over-year, Receivables - Net advanced 18.43% in 2023 and gained 2.55% in 2025.
• Over 5 years, Receivables - Net stood at $119.7 million in 2022, then gained by 9.62% to $131.2 million in 2023, then gained by 14.72% to $150.5 million in 2024, then advanced by 5.78% to $159.2 million in 2025, then increased by 5.14% to $167.4 million in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $167.4 million in Q1 2026, $159.2 million in Q4 2025, and $155.3 million in Q3 2025.